Ambrisentan: A Comprehensive Guide to Pulmonary Hypertension Treatment

Key Points About Ambrisentan

Ambrisentan is a prescription medication primarily used to treat pulmonary arterial hypertension (PAH) and related conditions. It works by relaxing the blood vessels in the lungs, which helps lower blood pressure and improve exercise capacity. Ambrisentan is typically taken once daily, and like all medications, it may cause side effects. It’s important to follow your doctor’s instructions carefully. If you have any questions about your treatment, consider consulting one of our telemedicine providers today.

Ambrisentan: Brand and Generic Names

US Brand Name: Letairis

Generic Name: Ambrisentan

The generic name refers to the active ingredient, while the brand name is assigned by the manufacturer. For clarity, this article will primarily use the generic name, Ambrisentan.

Pharmacologic Category: Endothelin Receptor Antagonists (ERA)

Ambrisentan belongs to a class of medications known as Endothelin Receptor Antagonists (ERA). Other drugs in this category include bosentan and macitentan, which are also used to treat pulmonary arterial hypertension by blocking endothelin, a substance that causes blood vessels to constrict.

Ambrisentan Dosage Guidelines

Ambrisentan is prescribed for various conditions, primarily those affecting the lungs and heart. It’s essential to follow your doctor’s dosing instructions precisely. Do not adjust your dose without consulting a healthcare provider. If you have concerns about your dosage, you can schedule a telemedicine appointment with one of our providers.

Ambrisentan Dosage for Pulmonary Arterial Hypertension (PAH)

Initial Dose: 5 mg orally once daily

Maintenance Dose: May increase to 10 mg once daily if tolerated

Duration: Long-term treatment as directed by your doctor

Ambrisentan Dosage for Chronic Thromboembolic Pulmonary Hypertension

Initial Dose: 5 mg orally once daily

Maintenance Dose: May increase to 10 mg once daily if tolerated

Duration: Long-term treatment as directed by your doctor

Ambrisentan Dosage for Heart Failure

Initial Dose: 5 mg orally once daily

Maintenance Dose: May increase to 10 mg once daily if tolerated

Duration: Long-term treatment as directed by your doctor

Ambrisentan Dosage for Eisenmenger Syndrome

Initial Dose: 5 mg orally once daily

Maintenance Dose: May increase to 10 mg once daily if tolerated

Duration: Long-term treatment as directed by your doctor

Ambrisentan Dosage for Idiopathic Pulmonary Fibrosis

Initial Dose: 5 mg orally once daily

Maintenance Dose: May increase to 10 mg once daily if tolerated

Duration: Long-term treatment as directed by your doctor

Ambrisentan Dosage for Scleroderma

Initial Dose: 5 mg orally once daily

Maintenance Dose: May increase to 10 mg once daily if tolerated

Duration: Long-term treatment as directed by your doctor

Ambrisentan Dosage for Congenital Heart Disease

Initial Dose: 5 mg orally once daily

Maintenance Dose: May increase to 10 mg once daily if tolerated

Duration: Long-term treatment as directed by your doctor

Ambrisentan Dosage for Left Heart Disease

Initial Dose: 5 mg orally once daily

Maintenance Dose: May increase to 10 mg once daily if tolerated

Duration: Long-term treatment as directed by your doctor

Ambrisentan Dosage for Pulmonary Veno-Occlusive Disease

Initial Dose: 5 mg orally once daily

Maintenance Dose: May increase to 10 mg once daily if tolerated

Duration: Long-term treatment as directed by your doctor

Ambrisentan Dosage for Systemic Sclerosis

Initial Dose: 5 mg orally once daily

Maintenance Dose: May increase to 10 mg once daily if tolerated

Duration: Long-term treatment as directed by your doctor

Ambrisentan Dosage Forms and Strengths

Ambrisentan is available in tablet form, with two strengths: 5 mg and 10 mg.

How to Take Ambrisentan: Administration Instructions

Ambrisentan should be taken once daily, with or without food. Swallow the tablet whole—do not crush, chew, or break it. To maintain consistent levels of the medication in your body, take your dose at the same time each day. If you miss a dose, take it as soon as you remember. However, if it’s almost time for your next dose, skip the missed dose and resume your regular schedule. Never take two doses at once.

Ambrisentan Contraindications

A contraindication is a specific condition where a medication should not be used because it may cause harm. If you have any of the following conditions, you should not take Ambrisentan unless your healthcare provider advises otherwise:

1. Pregnancy: Ambrisentan can cause serious birth defects and is contraindicated during pregnancy due to its risk to the fetus.
2. Severe liver disease: If you have severe liver problems, your body may not process Ambrisentan properly, leading to increased side effects or toxicity.
3. Idiopathic Pulmonary Fibrosis (IPF): Ambrisentan has not been shown to be effective for IPF and may worsen the condition.
4. Allergy to Ambrisentan or its ingredients: If you’ve had an allergic reaction to Ambrisentan, do not take it again, as it could cause a life-threatening reaction.

Ambrisentan Drug Interactions

Ambrisentan can interact with other medications, potentially increasing side effects or reducing the effectiveness of one or both drugs. Be sure to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Common medications that may interact with Ambrisentan include:

1. Cyclosporine (Gengraf, Neoral, Sandimmune): Taking cyclosporine with Ambrisentan can raise Ambrisentan levels in your blood, increasing the risk of side effects.
2. Rifampin (Rifadin, Rimactane): Rifampin can reduce Ambrisentan’s effectiveness by speeding up its breakdown in the liver.
3. Ketoconazole (Nizoral): This antifungal medication can increase Ambrisentan levels in your blood, raising the risk of side effects.
4. Warfarin (Coumadin, Jantoven): Ambrisentan may affect how your body processes warfarin, increasing the risk of bleeding.

Ambrisentan in Pregnancy

Is it safe to take Ambrisentan when pregnant?

No, Ambrisentan is not safe during pregnancy. It falls under the FDA’s Pregnancy Category X, meaning it has been shown to cause birth defects in animal studies and should not be used by pregnant women. If you are pregnant or planning to become pregnant, inform your healthcare provider immediately. Women of childbearing age should use reliable contraception while taking Ambrisentan and for at least one month after stopping the medication.

Ambrisentan while Breastfeeding

Is it safe to take Ambrisentan while breastfeeding?

Ambrisentan is not recommended during breastfeeding. There is not enough information to determine whether it passes into breast milk or if it could harm a nursing infant. If you are breastfeeding or planning to breastfeed, consult your healthcare provider to discuss alternative treatments.

Estimated Cost of Ambrisentan

The cost of a 30-day supply of Ambrisentan without insurance can vary depending on the dosage and the pharmacy. With a GoodRx coupon, the price typically ranges from $1,000 to $2,000 for a 30-day supply. Prices may fluctuate, so it’s a good idea to check with your pharmacy or use a discount service like GoodRx to find the best price available.

Possible Alternatives to Ambrisentan

If Ambrisentan is not suitable for you, other treatment options are available for the conditions it treats. Always consult your healthcare provider before making any changes to your treatment plan. Our telemedicine providers are also available to help you explore these alternatives.

Pulmonary Arterial Hypertension (PAH) Treatment Alternatives

Other medications, such as sildenafil (Revatio), tadalafil (Adcirca), or bosentan (Tracleer), may be prescribed. In addition, lifestyle changes like regular exercise, following a low-sodium diet, and avoiding high altitudes can help manage symptoms.

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Treatment

Riociguat (Adempas) is another medication option. In some cases, surgery may be necessary to remove blood clots from the lungs.

Heart Failure Treatment Options

Common medications include ACE inhibitors, beta-blockers, and diuretics. Lifestyle changes, such as reducing salt intake, maintaining a healthy weight, and engaging in regular physical activity, are also important for managing heart failure.

Eisenmenger Syndrome Treatment

Treatment may involve oxygen therapy, anticoagulants, or medications to manage pulmonary hypertension. Avoiding strenuous physical activity is often recommended to prevent complications.

Idiopathic Pulmonary Fibrosis (IPF) Treatment

Nintedanib (Ofev) and pirfenidone (Esbriet) are alternative medications for IPF. Pulmonary rehabilitation and oxygen therapy may also help improve quality of life.

Scleroderma Treatment Options

Treatment may include immunosuppressants, corticosteroids, or other medications to manage symptoms. Physical therapy and proper skin care can also be beneficial for individuals with scleroderma.

Congenital Heart Disease Treatment

Treatment for congenital heart disease depends on the type of defect and may involve medications, surgery, or catheter-based procedures. Regular monitoring and lifestyle changes are essential for managing the condition.

Left Heart Disease Treatment

Medications such as diuretics, ACE inhibitors, or beta-blockers may be prescribed to manage left heart disease. Lifestyle changes, including reducing salt intake and controlling blood pressure, are also crucial for treatment.

Pulmonary Veno-Occlusive Disease (PVOD) Treatment

Treatment options for PVOD are limited, but in severe cases, lung transplantation may be considered. Oxygen therapy and diuretics may help manage symptoms in the meantime.

Systemic Sclerosis Treatment

Treatment for systemic sclerosis may involve immunosuppressive drugs, physical therapy, and medications to manage specific symptoms, such as Raynaud’s phenomenon or gastrointestinal issues.

Recent Updates on Ambrisentan Research

Recent studies have focused on the long-term safety and effectiveness of Ambrisentan in treating pulmonary arterial hypertension (PAH). A 2021 study published in the journal Chest found that Ambrisentan, when combined with tadalafil, significantly improved exercise capacity and delayed disease progression in PAH patients. Ongoing research is also exploring the potential of Ambrisentan in combination therapies for other types of pulmonary hypertension, including chronic thromboembolic pulmonary hypertension (CTEPH).

Researchers are also investigating the use of Ambrisentan in patients with connective tissue diseases, such as systemic sclerosis, to determine if it can help manage pulmonary complications. While these studies are still in the early stages, they offer hope for expanding the use of Ambrisentan in other conditions.

It’s important to stay informed about the latest research and discuss any new treatment options with your healthcare provider. Our telemedicine team is here to help you stay up to date and make informed decisions about your care.

James Kingsley

Learn More